These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34292118)

  • 1. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group.
    Palanques-Pastor T; Megías-Vericat JE; Martínez P; López Lorenzo JL; Cornago Navascués J; Rodriguez Macias G; Cano I; Arnan Sangerman M; Vidriales Vicente MB; Algarra Algarra JL; Foncillas MÁ; Herrera P; Botella Prieto C; Vives S; Figuera Álvarez Á; Cuevas Palomares L; Sobas M; Contento Gonzalo A; Cuello García R; Amutio Diez ME; De Miguel Llorente D; Navas Elorza B; Bergua Burgues JM; Bernal Del Castillo T; Mateos Rodríguez MC; de Cabo López E; Franco Villegas AC; García Boyero R; Escolano Escobar C; Seri Merino C; Cervero C; Roldán Pérez A; Hermosín Ramos L; Cervera Calvo M; Olave MT; Villafuerte Gutiérrez P; de Laiglesiai A; Serrano J; Najera Irazu MJ; Piñana JL; Sanz MÁ; Martínez-López J; Montesinos P
    Leuk Lymphoma; 2021 Dec; 62(12):2928-2938. PubMed ID: 34292118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.
    Stahl M; Narendra V; Jee J; Derkach A; Maloy M; Geyer MB; Mato AR; Roeker LE; Tallman MS; Shah GL; Daniyan A; Goldberg AD
    Leuk Lymphoma; 2021 Aug; 62(8):1940-1948. PubMed ID: 34180767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
    Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH
    Turk J Haematol; 2022 Feb; 39(1):43-54. PubMed ID: 34521187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of SARS-CoV-2 infection on patients with hematological malignancies: a retrospective study.
    Zhao H; He Y; Li Z; Huang Y; Ying Y; Huang Z
    Hematology; 2023 Dec; 28(1):2288480. PubMed ID: 38063157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral response to mRNA-based COVID-19 vaccine in patients with myeloid malignancies.
    Mori A; Onozawa M; Tsukamoto S; Ishio T; Yokoyama E; Izumiyama K; Saito M; Muraki H; Morioka M; Teshima T; Kondo T
    Br J Haematol; 2022 Jun; 197(6):691-696. PubMed ID: 35226358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.
    Young BE; Ong SWX; Kalimuddin S; Low JG; Tan SY; Loh J; Ng OT; Marimuthu K; Ang LW; Mak TM; Lau SK; Anderson DE; Chan KS; Tan TY; Ng TY; Cui L; Said Z; Kurupatham L; Chen MI; Chan M; Vasoo S; Wang LF; Tan BH; Lin RTP; Lee VJM; Leo YS; Lye DC;
    JAMA; 2020 Apr; 323(15):1488-1494. PubMed ID: 32125362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study.
    Hong KS; Lee KH; Chung JH; Shin KC; Choi EY; Jin HJ; Jang JG; Lee W; Ahn JH
    Yonsei Med J; 2020 May; 61(5):431-437. PubMed ID: 32390367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population.
    Bonifacio M; Tiribelli M; Miggiano MC; Abruzzese E; Binotto G; Scaffidi L; Cordioli M; Damiani D; Di Bona E; Trawinska MM; Tanasi I; Dubbini MV; Velotta V; Ceccarelli G; Pierdomenico E; Lo Schirico M; Semenzato G; Ruggeri M; Fanin R; Tacconelli E; Pizzolo G; Krampera M
    Cancer Med; 2021 Sep; 10(18):6310-6316. PubMed ID: 34464516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Special case of a patient in the blast phase of chronic myeloid leukemia successfully treated with tocilizumab during critical SARS-CoV-2 infection.
    Bouchlarhem A; Es-Saad O; Haddar L; Lamzouri O; Elaidouni G; Mimouni H; Bkiyar H; Housni B
    J Int Med Res; 2022 Mar; 50(3):3000605221082875. PubMed ID: 35301903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
    Alavi Darazam I; Hatami F; Rabiei MM; Pourhoseingholi MA; Moradi O; Shokouhi S; Hajesmaeili MR; Shabani M; Irvani SSN
    Trials; 2020 Oct; 21(1):880. PubMed ID: 33106183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression.
    Sieni E; Pegoraro F; Casini T; Tondo A; Bortone B; Moriondo M; Azzari C; Galli L; Favre C
    Br J Haematol; 2020 Jun; 189(6):e222-e224. PubMed ID: 32369615
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal Invasive Pulmonary Aspergillosis in COVID-19 Patient with Acute Myeloid Leukemia in Iran.
    Nasri E; Shoaei P; Vakili B; Mirhendi H; Sadeghi S; Hajiahmadi S; Sadeghi A; Vaezi A; Badali H; Fakhim H
    Mycopathologia; 2020 Dec; 185(6):1077-1084. PubMed ID: 33009966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned for successful treatment of AML in the second wave of COVID-19 outbreak.
    Ramírez-López A; Lázaro Del Campo P; Humala K; De la Cruz Benito B; Sánchez-Vadillo I; López de la Guía A; de Paz Arias R; Jiménez-Yuste V; Canales M
    Leuk Lymphoma; 2021 Aug; 62(8):2034-2036. PubMed ID: 33645389
    [No Abstract]   [Full Text] [Related]  

  • 15. Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review.
    Vargas M; Servillo G; Einav S
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8592-8605. PubMed ID: 32894567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
    Cao B; Wang Y; Wen D; Liu W; Wang J; Fan G; Ruan L; Song B; Cai Y; Wei M; Li X; Xia J; Chen N; Xiang J; Yu T; Bai T; Xie X; Zhang L; Li C; Yuan Y; Chen H; Li H; Huang H; Tu S; Gong F; Liu Y; Wei Y; Dong C; Zhou F; Gu X; Xu J; Liu Z; Zhang Y; Li H; Shang L; Wang K; Li K; Zhou X; Dong X; Qu Z; Lu S; Hu X; Ruan S; Luo S; Wu J; Peng L; Cheng F; Pan L; Zou J; Jia C; Wang J; Liu X; Wang S; Wu X; Ge Q; He J; Zhan H; Qiu F; Guo L; Huang C; Jaki T; Hayden FG; Horby PW; Zhang D; Wang C
    N Engl J Med; 2020 May; 382(19):1787-1799. PubMed ID: 32187464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses.
    Kang CK; Seong MW; Choi SJ; Kim TS; Choe PG; Song SH; Kim NJ; Park WB; Oh MD
    Korean J Intern Med; 2020 Jul; 35(4):782-787. PubMed ID: 32460458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases.
    Arouche TDS; Martins AY; Ramalho TC; Júnior RNC; Costa FLP; Filho TSA; Neto AMJC
    J Nanosci Nanotechnol; 2021 Apr; 21(4):2075-2089. PubMed ID: 33500022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapeutic options for coronavirus disease 2019 (COVID-19)-lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol.
    Zhang ZL; Zhong H; Liu YX; Le KJ; Cui M; Yu YT; Gu ZC; Gao Y; Lin HW
    Ann Transl Med; 2020 Nov; 8(22):1527. PubMed ID: 33313272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of SARS-CoV-2 Entry Factors on Myeloid Cancers.
    Alshareef A
    J Nippon Med Sch; 2022; 89(1):95-101. PubMed ID: 35283406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.